{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T20:29:31Z","timestamp":1773001771175,"version":"3.50.1"},"reference-count":98,"publisher":"Tech Science Press","issue":"2","license":[{"start":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T00:00:00Z","timestamp":1737244800000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/doi.org\/10.32604\/TSP-CROSSMARKPOLICY"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2025]]},"DOI":"10.32604\/or.2024.052939","type":"journal-article","created":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T08:24:47Z","timestamp":1726302287000},"page":"283-300","update-policy":"https:\/\/doi.org\/10.32604\/tsp-crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["FOXR2 in cancer development: emerging player and therapeutic opportunities"],"prefix":"10.32604","volume":"33","author":[{"given":"PIAO","family":"YANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HANIE","family":"MAHAKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NASER","family":"KALHOR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ASHKAN","family":"DIRBAZIYAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHARAFALDIN","family":"AL-MUSAWI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MOHSEN","family":"SHEYKHHASAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"REZA","family":"HEIDARI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MOHSEN","family":"CHAMANARA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PAOLA","family":"DAMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AMIRHOSSEIN","family":"AHMADIEH-YAZDI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HAMED","family":"MANOOCHEHRI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HAMID","family":"TANZADEHPANAH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17807","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2174\/18755666MTA3oNDYb1","article-title":"The functional role of long non-coding RNA uca1 in human multiple cancers: a review study","volume":"21","author":"Hosseini","year":"2021","journal-title":"Curr Mol Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1017\/erm.2021.17","article-title":"DLX6-AS1: a putative lncRNA candidate in multiple human cancers","volume":"23","author":"Sheykhhasan","year":"2021","journal-title":"Expert Rev Mol Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ncrna9010001","article-title":"FLVCR1-AS1 and FBXL19-AS1: two putative lncRNA candidates in multiple human cancers","volume":"9","author":"Sheykhhasan","year":"2023","journal-title":"Non-Coding RNA"},{"key":"ref4","first-page":"30","author":"Sheykhhassan","year":"2024","journal-title":"Critical developments in cancer immunotherapy"},{"key":"ref5","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA: A Cancer J Clinical"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrg2523","article-title":"The evolution of Fox genes and their role in development and disease","volume":"10","author":"Hannenhalli","year":"2009","journal-title":"Nat Rev Genet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12943-019-0938-x","article-title":"The forkhead-box family of transcription factors: key molecular players in colorectal cancer pathogenesis","volume":"18","author":"Laissue","year":"2019","journal-title":"Mol Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrc2223","article-title":"The emerging roles of forkhead box (Fox) proteins in cancer","volume":"7","author":"Myatt","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3389\/fonc.2014.00305","article-title":"Forkhead box transcription factors in cancer initiation, progression and chemotherapeutic drug response","volume":"4","author":"Lam","year":"2014","journal-title":"Front Oncol"},{"key":"ref10","first-page":"219","volume":"25","author":"Katoh","year":"2004","journal-title":"Int J Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.celrep.2016.06.004","article-title":"FOXR2 interacts with MYC to promote its transcriptional activities and tumorigenesis","volume":"16","author":"Li","year":"2016","journal-title":"Cell Rep"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/ng.2641","article-title":"Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis","volume":"45","author":"Rahrmann","year":"2013","journal-title":"Nat Genet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1158\/0008-5472.CAN-13-1523","article-title":"Identification of FoxR2 as an oncogene in medulloblastoma","volume":"74","author":"Koso","year":"2014","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1158\/0008-5472.CAN-22-0671","article-title":"FOXR2 is an epigenetically regulated pan-cancer oncogene that activates ETS transcriptional circuits","volume":"82","author":"Tsai","year":"2022","journal-title":"Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"101714","DOI":"10.1016\/j.jbc.2022.101714","article-title":"Interaction of transcription factor FoxO3 with histone acetyltransferase complex subunit TRRAP modulates gene expression and apoptosis","volume":"298","author":"Fusi","year":"2022","journal-title":"J Biol Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"D648","DOI":"10.1093\/nar\/gkab1006","article-title":"The IntAct database: efficient access to fine-grained molecular interaction data","volume":"50","author":"del Toro","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1200\/JCO.20.02540","volume":"39","author":"Schmitt-Hoffner","year":"2021","journal-title":"J Clin Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2016.01.015","article-title":"New brain tumor entities emerge from molecular classification of CNS-PNETs","volume":"164","author":"Sturm","year":"2016","journal-title":"Cell"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1097-2765(02)00459-8","article-title":"Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4","volume":"9","author":"Cirillo","year":"2002","journal-title":"Mol Cell"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/10935266211018554","article-title":"Evaluation and diagnosis of central nervous system embryonal tumors (Non-Medulloblastoma)","volume":"25","author":"Cotter","year":"2022","journal-title":"Pediatr Dev Pathol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/neuonc\/noz067","article-title":"Foxr2 promotes formation of CNS-embryonal tumors in a Trp53-deficient background","volume":"21","author":"Poh","year":"2019","journal-title":"Neuro Oncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/neuonc\/noab136","article-title":"Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study","volume":"23","author":"Von Hoff","year":"2021","journal-title":"Neuro Oncol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-3-031-51078-6_9","author":"Lacruz","year":"2023","journal-title":"Central nervous system tumors: diagnostic pathology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/jon.13095","article-title":"Neuroimaging features of FOXR2-activated CNS neuroblastoma: a case series and systematic review","volume":"33","author":"Shimazaki","year":"2023","journal-title":"J Neuroimaging"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40478-023-01536-7","article-title":"CNS neuroblastoma, FOXR2-activated and its mimics: a relevant panel approach for work-up and accurate diagnosis of this rare neoplasm","volume":"11","author":"Tauzi\u00e8de-Espariat","year":"2023","journal-title":"Acta Neuropathol Commun"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Buemi F, Campos A, Bell D, Gaillard F, Murphy A. CNS neuroblastoma, FOXR2-activated. Available from: https:\/\/doi.org\/10.53347\/rID-96620. [Accessed 2024].","DOI":"10.53347\/rID-96620"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"56255","DOI":"10.18632\/oncotarget.17447","article-title":"FoxR2 promotes glioma proliferation by suppression of the p27 pathway","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40364-021-00323-7","article-title":"The Wnt signaling pathway in tumorigenesis, pharmacological targets, and drug development for cancer therapy","volume":"9","author":"Wang","year":"2021","journal-title":"Biomark Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3322\/caac.21772","article-title":"Colorectal cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA A Cancer J Clinicians"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"10459","DOI":"10.1007\/s13277-016-4923-3","article-title":"FOXR2 contributes to cell proliferation and malignancy in human hepatocellular carcinoma","volume":"37","author":"Wang","year":"2016","journal-title":"Tumor Biol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbrc.2018.04.046","article-title":"Down-regulation of FOXR2 inhibits non-small cell lung cancer cell proliferation and invasion through the Wnt\/\u03b2-catenin signaling pathway","volume":"500","author":"Wang","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbrc.2021.03.137","article-title":"E3 ubiquitin ligase PJA1 regulates lung adenocarcinoma apoptosis and invasion through promoting FOXR2 degradation","volume":"556","author":"Luo","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1080\/15384101.2021.1974788","article-title":"Circ-PGC increases the expression of FOXR2 by targeting miR-532-3p to promote the development of non-small cell lung cancer","volume":"20","author":"Xia","year":"2021","journal-title":"Cell Cycle"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1007\/s13277-015-4437-4","article-title":"High expression of FOXR2 in breast cancer correlates with poor prognosis","volume":"37","author":"Song","year":"2016","journal-title":"Tumor Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"7780","DOI":"10.1002\/jcb.27148","article-title":"Forkhead-box R2 promotes metastasis and growth by stimulating angiogenesis and activating hedgehog signaling pathway in ovarian cancer","volume":"119","author":"Li","year":"2018","journal-title":"J Cell Biochem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.omtn.2019.12.005","article-title":"circCELSR1 (hsa_circ_0063809) contributes to paclitaxel resistance of ovarian cancer cells by regulating FOXR2 expression via miR-1252","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s11010-022-04548-4","article-title":"circANKRD17(has_circ_0007883) confers paclitaxel resistance of ovarian cancer via interacting with FUS to stabilize FOXR2","volume":"478","author":"Liang","year":"2023","journal-title":"Mol Cell Biochem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.biopha.2016.12.120","article-title":"Knockdown of FOXR2 suppresses the tumorigenesis, growth and metastasis of prostate cancer","volume":"87","author":"Xu","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2827435","DOI":"10.1155\/2017\/2827435","article-title":"miR-202 suppresses cell proliferation by targeting FOXR2 in endometrial adenocarcinoma","volume":"2017","author":"Deng","year":"2017","journal-title":"Dis Markers"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"v179","DOI":"10.1093\/neuonc\/nov228.02","article-title":"PTPS-02FOXR2: an oncogene in medulloblastoma","volume":"17","author":"Das","year":"2015","journal-title":"Neuro Oncol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"iii323","DOI":"10.1093\/neuonc\/noaa222.207","article-title":"ETMR-03. The role of FOXR2 in pediatric brain cancer","volume":"22","author":"Schmitt-Hoffner","year":"2020","journal-title":"Neuro Oncol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/neuonc\/noz102","article-title":"A fox with many faces: FOXR2 and embryonal brain tumors","volume":"21","author":"Eberhart","year":"2019","journal-title":"Neuro Oncol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1158\/0008-5472.CAN-18-1261","article-title":"Sleeping beauty insertional mutagenesis reveals important genetic drivers of central nervous system embryonal tumors","volume":"79","author":"Beckmann","year":"2019","journal-title":"Cancer Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s10014-020-00370-2","article-title":"Central nervous system neuroblastic tumor with FOXR2 activation presenting both neuronal and glial differentiation: a case report","volume":"37","author":"Furuta","year":"2020","journal-title":"Brain Tumor Pathol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4018\/979-8-3693-1281-0.ch002","author":"Seyedebrahimi","year":"2024","journal-title":"Deep learning approaches for early diagnosis of neurodegenerative diseases"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3727\/096504016X14771034190471","article-title":"FOXR2 promotes the proliferation, invasion, and epithelial-mesenchymal transition in human colorectal cancer cells","volume":"25","author":"Lu","year":"2017","journal-title":"Oncol Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA A Cancer J Clinicians"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"G1124","DOI":"10.1152\/ajpgi.00035.2016","article-title":"Transcriptomic and CRISPR\/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer","volume":"310","author":"Vorvis","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1002\/jcb.27657","article-title":"CircABCB10 promotes nonsmall cell lung cancer cell proliferation and migration by regulating the miR-1252\/FOXR2 axis","volume":"120","author":"Tian","year":"2019","journal-title":"J Cell Biochem"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/cac2.12358","article-title":"Breast cancer: an up-to-date review and future perspectives","volume":"42","author":"Hong","year":"2022","journal-title":"Cancer Commun"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41389-023-00497-9","volume":"12","author":"Yan","year":"2023","journal-title":"Oncogenesis"},{"key":"ref53","unstructured":"American Cancer SocietyOvarian cancer statistics. Available from: https:\/\/www.cancer.org\/cancer\/types\/ovarian-cancer\/about\/key-statistics.html. [Accessed 2024]."},{"key":"ref54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/AOG.0000000000005211","article-title":"Executive summary of the ovarian cancer evidence review conference","volume":"142","author":"Burke","year":"2023","journal-title":"Obstet Gynecol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"473","DOI":"10.7150\/jca.87881","article-title":"Impact of treatment delay on the prognosis of patients with ovarian cancer: a population-based study using the surveillance, epidemiology, and end results database","volume":"15","author":"Zhao","year":"2024","journal-title":"J Cancer"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41416-022-01925-0","article-title":"A novel circulating miRNA panel for non-invasive ovarian cancer diagnosis and prognosis","volume":"127","author":"Gahlawat","year":"2022","journal-title":"Br J Cancer"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.3390\/cancers14122885","article-title":"Current and emerging methods for ovarian cancer screening and diagnostics: a comprehensive review","volume":"14","author":"Liberto","year":"2022","journal-title":"Cancers"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"213","DOI":"10.21873\/cgp.20442","volume":"21","author":"Weidle","year":"2024","journal-title":"Cancer Genom Proteomics"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","article-title":"Endometrial cancer","volume":"399","author":"Crosbie","year":"2022","journal-title":"Lancet"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"699","DOI":"10.17219\/acem\/171382","article-title":"Combination of serum FOXR2 and transvaginal three-dimensional power Doppler ultrasonography in the diagnosis of uterine lesions","volume":"33","author":"Zhang","year":"2023","journal-title":"Adv Clin Exp Med"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/bioengineering5040078","article-title":"Embryonal tumors of the central nervous system in children: the era of targeted therapeutics","volume":"5","author":"Kram","year":"2018","journal-title":"Bioengineering"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11060-024-04667-6","article-title":"Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapse","volume":"168","author":"Bielamowicz","year":"2024","journal-title":"J Neurooncol"},{"key":"ref65","unstructured":"PDQ\u00ae Pediatric Treatment Editorial Board. Childhood medulloblastoma and other central nervous system embryonal tumors treatment. Available from: https:\/\/www.cancer.gov\/types\/brain\/hp\/child-cns-embryonal-treatment-pdq. [Accessed 2024]."},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1177\/0883073809341668","article-title":"Medulloblastoma","volume":"24","author":"Dhall","year":"2009","journal-title":"J Child Neurol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"vi191","DOI":"10.1093\/neuonc\/noz175.795","article-title":"PDTM-19. MYC and FAK\/SRC combination treatment of FOXR2-high brain tumors","volume":"21","author":"Beckmann","year":"2019","journal-title":"Neuro Oncol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"i69","DOI":"10.1093\/neuonc\/noy059.189","article-title":"EMBR-04. What the fox say? A molecular analysis of FOXR2 in pediatric brain tumors","volume":"20","author":"Van Rijn","year":"2018","journal-title":"Neuro Oncol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1158\/1538-7445.AM2016-1121","article-title":"Abstract 1121: validation of FOXR2 and ARHGAP36 as oncogenes in medulloblastoma","volume":"76","author":"Jackson","year":"2016","journal-title":"Cancer Res"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1016\/j.neuron.2022.07.012","article-title":"Neuroblastoma: when differentiation goes awry","volume":"110","author":"Zeineldin","year":"2022","journal-title":"Neuron"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s40478-020-00984-9","article-title":"Molecular identification of CNS NB-FOXR2, CNS EFT-CIC, CNS HGNET-MN1 and CNS HGNET-BCOR pediatric brain tumors using tumor-specific signature genes","volume":"8","author":"\u0141astowska","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40478-021-01118-5","article-title":"Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation","volume":"9","author":"Korshunov","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.1158\/1538-7445.AM2022-5730","article-title":"Abstract 5730: FOXR2 is an oncogenic driver across adult and pediatric cancers","volume":"82","author":"Tsai","year":"2022","journal-title":"Cancer Res"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/jnen\/nlaa128","article-title":"Detailed clinical and histopathological description of 8 cases of molecularly defined CNS neuroblastomas","volume":"80","author":"Holsten","year":"2021","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"100814","DOI":"10.1016\/j.adro.2021.100814","article-title":"Pineal parenchymal tumors of intermediate differentiation treated with ventricular radiation and temozolomide","volume":"7","author":"Low","year":"2022","journal-title":"Adv Rad Oncol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"116399","DOI":"10.1016\/j.bcp.2024.116399","article-title":"Unveiling therapeutic potential: adipose tissue-derived mesenchymal stem cells and their exosomes in the management of diabetes mellitus, wound healing, and chronic ulcers","volume":"226","author":"Ahmadieh-Yazdi","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00401-021-02284-5","article-title":"Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study","volume":"141","author":"Liu","year":"2021","journal-title":"Acta Neuropathol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.3390\/cancers14092296","article-title":"Glioma stem cells in pediatric high-grade gliomas: from current knowledge to future perspectives","volume":"14","author":"Da-Veiga","year":"2022","journal-title":"Cancers"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"100899","DOI":"10.1016\/j.neo.2023.100899","article-title":"Therapeutic avenues for targeting treatment challenges of diffuse midline gliomas","volume":"40","author":"Noon","year":"2023","journal-title":"Neoplasia"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1158\/1538-7445.AM2022-1462","article-title":"Abstract 1462: oncogenic activation of FOXR2 driven by somatic acquisition of a LINE-1 promoter in pediatric high-grade glioma","volume":"82","author":"Chen","year":"2022","journal-title":"Cancer Res"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00401-022-02420-9","article-title":"Somatic LINE-1 promoter acquisition drives oncogenic FOXR2 activation in pediatric brain tumor","volume":"143","author":"Flasch","year":"2022","journal-title":"Acta Neuropathol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO classification of thyroid neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"Endocr Pathol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"104188","DOI":"10.1016\/j.critrevonc.2023.104188","article-title":"Insights into the molecular roles of FOXR2 in the pathology of primary pediatric brain tumors","volume":"192","author":"Gharbaran","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/1440-1681.13286","article-title":"Down-regulation of FOXR2 inhibits hypoxia-driven ROS-induced migration and invasion of thyroid cancer cells via regulation of the hedgehog pathway","volume":"47","author":"Liao","year":"2020","journal-title":"Clin Exp Pharma Physio"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/gcc.22204","article-title":"Deregulated FOX genes in H odgkin lymphoma","volume":"53","author":"Nagel","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/cancers10040091","article-title":"Chromosomal instability in hodgkin lymphoma: an in-depth review and perspectives","volume":"10","author":"Cuceu","year":"2018","journal-title":"Cancers"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1007\/s00018-015-1918-y","article-title":"Bone microenvironment signals in osteosarcoma development","volume":"72","author":"Alfranca","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"ref88","first-page":"201","article-title":"The relationship of FOXR2 gene expression profile with epithelial-mesenchymal transition related markers in epithelial ovarian cancer","volume":"33","author":"Asadollahi","year":"2020","journal-title":"Klin Onkol"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3390\/cancers13020242","article-title":"Personalized medicine: recent progress in cancer therapy","volume":"13","author":"Hoeben","year":"2021","journal-title":"Cancers"},{"key":"ref90","first-page":"313","article-title":"RNA interference and its role in cancer therapy","volume":"4","author":"Mansoori","year":"2014","journal-title":"Adv Pharm Bull"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3390\/ijms23010573","article-title":"Targeting cancer with CRISPR\/Cas9-based therapy","volume":"23","author":"Balon","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1002\/mco2.181","article-title":"Small molecule inhibitors targeting the cancers","volume":"3","author":"Liu","year":"2022","journal-title":"MedComm"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.32604\/biocell.2023.043351","article-title":"Exosomes in viral infection: effects for pathogenesis and treatment strategies","volume":"47","author":"Heidari","year":"2023","journal-title":"Biocell"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"100829","DOI":"10.1016\/j.neo.2022.100829","article-title":"Microbiota-driven mechanisms at different stages of cancer development","volume":"32","author":"Ivleva","year":"2022","journal-title":"Neoplasia"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3322\/caac.21398","article-title":"The role of the microbiome in cancer development and therapy","volume":"67","author":"Bhatt","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"e00927","DOI":"10.1128\/MRA.00927-19","article-title":"Improved draft genome sequence of microbacterium sp. strain LKL04, a bacterial endophyte associated with switchgrass plants","volume":"8","author":"Sahib","year":"2019","journal-title":"Microbiol Resour Announc"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1094\/PBIOMES-09-21-0054-A","article-title":"Genome sequence source of bacillus amyloliquefaciens strain GD4a, a bacterial endophyte associated with switchgrass plants","volume":"6","author":"Yang","year":"2022","journal-title":"Phytobiomes J"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1094\/MPMI-08-20-0222-A","article-title":"Genome sequence resource of bacillus sp. RRD69, a beneficial bacterial endophyte isolated from switchgrass plants","volume":"34","author":"Zhao","year":"2021","journal-title":"Mol Plant Microbe Interact"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/file.techscience.com\/files\/or\/2025\/TSP_OR-33-2\/OncolRes-33-02-52939\/OncolRes-33-52939.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T07:19:05Z","timestamp":1741331945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v33n2\/59305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":98,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2024.052939","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"2024-04-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-16","order":2,"name":"published","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}]}}